India Pacemaker Market is flourishing due to the rising prevalence of cardiovascular diseases, growing geriatric population, increasing life expectancy, and government’s supportive reimbursement ...
Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...
Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer ...
About Boston Scientific Corporation and Thermo Fisher Scientific Inc ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, ...
Boston Scientific Corporation develops ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor ...
In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research ...
City officials said pilot program in Jamaica Plain didn't prove effective, but a nonprofit said there were fewer rats around ...
New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...
Although some studies have demonstrated that, given appropriate precautions, MRI can be safely performed in patients with selected implantable pacemakers, MRI in pacemaker patients is still ...
Shares of Boston Scientific Corp. BSX slumped 0.15% to $84.41 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to ...
The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...
Boston Scientific Corp. closed $0.35 short of its 52-week high ($84.89), which the company achieved on September 19th.